FIELD: veterinary medicine.
SUBSTANCE: for correction of skeletal muscle ischemia in rats with ischemia of lower leg muscles, modelled on the second day of the experiment, resveratrol is intragastrically administered in a daily dose of 2.0 mg/kg every 46 hours of the first 7 days of the experiment. The microcirculation level in the muscle of lower leg was evaluated on the 28th day of induction of ischemia.
EFFECT: effective treatment of skeletal muscle ischemia in the experiment due to stimulation of neoangiogenesis.
1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PHARMACOLOGICAL CORRECTION OF SKELETAL MUSCLE ISCHEMIA WITH L-NORVALINE | 2012 |
|
RU2507596C1 |
METHOD FOR STIMULATING NEOANGIOGENESIS IN ISCHEMIC SKELETAL MUSCLE | 2014 |
|
RU2547692C1 |
METHOD OF PHARMACOLOGICAL CORRECTION OF SCELETAL MUSCLE ISCHEMIA WITH SILNEDAFIL INCLUDING IN L-NAME INDUCED NITROGEN OXIDE DEFICIENCY | 2012 |
|
RU2497203C2 |
METHOD FOR PHARMACOLOGICAL STIMULATION OF NEOANGIOGENESIS IN TREATING ACUTE EXPERIMENTAL LIMB ISCHEMIA | 2014 |
|
RU2559937C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF SKELETAL MUSCLE ISCHEMIA WITH NICORANDYL | 2012 |
|
RU2507597C2 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF SCELETAL MUSCLE ISCHEMIA WITH MINOXIDIL | 2012 |
|
RU2497200C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH A COMBINATION OF SIMVASTATIN AND MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW | 2020 |
|
RU2735838C1 |
METHOD FOR SKELETAL MUSCLE EXPERIMENTAL ISCHEMIA PHARMACOLOGICAL CORRECTION USING SILDENAFIL AND PENTOXIFYLLINE IN COMBINED THERAPY | 2016 |
|
RU2618621C1 |
METHOD FOR SKELETAL MUSCLE EXPERIMENTAL ISCHEMIA PHARMACOLOGICAL CORRECTION USING TADALAFIL AND PENTOXIFYLLINE IN COMBINED THERAPY | 2016 |
|
RU2618620C1 |
METHOD FOR SKELETAL MUSCLE EXPERIMENTAL ISCHEMIA PHARMACOLOGICAL CORRECTION USING VARDENAFIL AND PENTOXIFYLLINE IN COMBINED THERAPY | 2016 |
|
RU2618622C1 |
Authors
Dates
2014-06-10—Published
2012-12-05—Filed